Careers Contact Us Home About us Our Pipeline Our Science Partnering News & Events Crescendo > Partnering Overview > Therapeutic Areas Therapeutic Areas Therapeutic Areas The Humabody® platform is exceptionally versatile and has advantages in a broad range of both technology applications and disease areas. Crescendo is actively seeking to expand its partnerships in both of these areas. Immuno-oncology Oncology Autoimmune / Inflammation Respiratory Neurology / CNS Metabolic / GI Dermatology Ophthalmology Humabodies can be configured into multi-specific formats for optimal, often unique target engagement, thereby accessing novel biology. Humabody half-life extension technology is available to tailor pharmacokinetics and pharmacodynamics to meet specific therapeutic requirements. A range of Humabody Vs against immuno-oncology targets is available for quick starts to projects. To explore ways in which we could help you achieve your drug development goals, please contact us. Humabody® and Multibody® are registered trademarks of Crescendo Biologics Ltd. Meditrina Building 260, Babraham Research Campus, Cambridge, CB22 3AT Cambridge Web Design